Press ReleaseAIMHI_wpuser2024-08-29T11:16:30+00:00

Press Release

Press Release

Calling Oncology Founders: Applications Open for the 2026 AIM-HI Venture Competition

Ellaye2026-01-14T15:14:36+00:00January 5, 2026|Press Release|

2025 NFCR Global Summit AIM-HI Recap: Discovery to Delivery

Ellaye2025-11-07T22:20:58+00:00November 7, 2025|Press Release|

AIM-HI Accelerator Fund Announces Winners of the 2025 Venture Competition

Ellaye2025-10-09T19:53:52+00:00October 9, 2025|Press Release|

Program Highlights: 2025 NFCR Global Summit (co-hosted by AIM-HI)

Ellaye2025-10-09T18:47:04+00:00October 6, 2025|Press Release|

2025 AIM‑HI Venture Competition Semi‑Finalists Announced!

Ellaye2025-07-14T18:54:42+00:00July 10, 2025|Press Release|

Tvardi Therapeutics Announced Closing of Merger with Cara Therapeutics

Ellaye2025-04-18T14:56:49+00:00April 18, 2025|Press Release|

AIMhi

AIM-HI Accelerator Fund is a 501(c)(3) tax-exempt nonprofit organization.

Tax ID #: 82-4322538

Address:

5515 Security Lane, Suite 1105
Rockville, MD 20852

Email:

info@aim-hiaccelerator.org

Phone:

1-800-321-CURE (2873)

what we do

Copyright © AIM-HI 2026 All Rights Reserved

AIMhi

AIM-HI Accelerator Fund is a 501(c)(3) tax-exempt nonprofit organization.

Tax ID #: 82-4322538

Copyright © AIM-HI 2026 All Rights Reserved